Understanding the intricate regulatory frameworks for pharmaceuticals, biotechnology, and medical devices within the European Union can be challenging. This topic offers practical insights and tailored guidance for legal professionals, ensuring compliance with EU directives and regulations while fostering innovation and safeguarding public health. Explore the latest developments, case law, and strategic considerations crucial for mastering the intricacies of life sciences law in the EU.
MLex: A surge in EU measures against cheap chemical imports from China and elsewhere has raised questions about the effectiveness of the EU’s trade...
The European Commission has published updated guidance to support battery-sector stakeholders preparing for the Digital Batteries Passport under...
This week's edition of EU Law weekly highlights includes analyses of the General Court’s trade mark decisions concerning George Orwell’s ‘Animal Farm'...
Law360, London: The EU's carbon import levy on emissions-intensive goods such as aluminium and cement will allow importers to reduce the cost of the...
HarmonisationDefinition of harmonisationHarmonisation, also known as standardisation or approximation, refers to the determination of EU-wide legally...
Indirect effect of EU lawWhat is indirect effect of EU law?The doctrine of indirect effect, or consistent interpretation, is a duty that national...
The EU Commercial Agents DirectiveThis Practice Note considers Council Directive 86/653/EEC (OJ L 382/17), the EU Commercial Agents Directive. It...
Infringement proceedings against EU Member StatesUnder Article 17(1) of the Treaty on European Union (TEU), one of the European Commission’s core...
Priority between loss reliefs in loss making companiesWhy does it matter?A company that is a member of a group and has incurred any of the types of losses available for surrender by way of group relief may, without any further rules, have more than one way in which to use the loss. There are a
Late payment penalties—inheritance taxWhile interest often accrues on overdue tax, the late payment of certain taxes may also attract a penalty. For information on the interest accruing on overdue tax, see Practice Notes: IHT—payment deadlines on death—Interest on IHT and Interest on late paid
If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit
Contributory negligence in personal injury claimsContributory negligence is a partial defence which can lead to a discount in damages.Other defences may also be relevant. See Practice Notes: Did the claimant consent to the risk of injury? and Was the claimant involved in an illegal activity?If a
0330 161 1234